Serum thioredoxin at allogeneic haematopoietic stem cell transplantation predicts acute graft‐versus‐host disease
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70739 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Masaharu Tamaki und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Thioredoxins. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Jichi Medical University, Japan Society for the Promotion of Science, Terumo Foundation for Life Sciences and Arts.
Abstract (Originalsprache)
Thioredoxin (TXN) is a component of a major reductive system in various eukaryotes. Although oxidative stress is considered to contribute to the development of acute graft‐versus‐host disease (GVHD), the clinical significance of TXN remains to be elucidated. The current study included 118 patients who had undergone their first allogeneic haematopoietic stem cell transplantation (allo‐HSCT) between 2022 and 2025, and their serum samples at day 0 were sequentially collected (training cohort). The study also assessed 47 patients who had undergone their first allo‐HSCT between 2012 and 2015 and whose serum at around day 0 had previously been cryopreserved and was available (validation cohort). The high‐TXN group showed a lower cumulative incidence of grade II–IV acute GVHD (100‐day incidence: 47.5% vs. 59.2%), although the difference did not reach statistical significance ( p = 0.058). The validation cohort demonstrated similar results (0% vs. 35.8%, p = 0.053). However, multivariate analysis revealed that high‐TXN group was significantly associated with a reduced risk of acute GVHD (hazard ratio [HR] 0.48, p = 0.031). In addition, the combination of TXN with clinical factors enhanced the predictive potential for acute GVHD compared with that of clinical factors alone ( p = 0.0039). TXN might be useful for predicting acute GVHD and could contribute to the establishment of a prediction model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
- Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
ORCID-Profile: Masaharu Tamaki, Hideki Nakasone, Kosuke Takano, Shunto Kawamura, Yukiko Misaki, Yosuke Okada, Akari Matsuoka, Tomohiro Meno, Nozomu Yoshino, Ayumi Gomyo, Machiko Kusuda, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Förderung
- Jichi Medical University
- Japan Society for the Promotion of Science
- Terumo Foundation for Life Sciences and Arts
- Japan Agency of Medical Research and Development (AMED)
- Japan Agency for Medical Research and Development
Zitieren
APA
Tamaki, M., Nakasone, H., Takano, K., Kawamura, S., Misaki, Y., Yoshimura, K., Okada, Y., Tanihara, A., Hashino, K., Yamamoto, K., Nakata, Y., Ishikawa, T., Matsuoka, A., Meno, T., Nakamura, Y., Kawamura, M., Takeshita, J., Yoshino, N., Gomyo, A., …, & Kanda, Y. (2026). Serum thioredoxin at allogeneic haematopoietic stem cell transplantation predicts acute graft‐versus‐host disease. British Journal of Haematology. https://doi.org/10.1111/bjh.70739
Vancouver
Tamaki M, Nakasone H, Takano K, Kawamura S, Misaki Y, Yoshimura K, et al. Serum thioredoxin at allogeneic haematopoietic stem cell transplantation predicts acute graft‐versus‐host disease. British Journal of Haematology. 2026. doi:10.1111/bjh.70739
BibTeX
@article{Tamaki2026,
author = {Tamaki, Masaharu and Nakasone, Hideki and Takano, Kosuke and Kawamura, Shunto and Misaki, Yukiko and Yoshimura, Kazuki and Okada, Yosuke and Tanihara, Aki and Hashino, Koki and Yamamoto, Kaisuke and Nakata, Yuya and Ishikawa, Takuto and Matsuoka, Akari and Meno, Tomohiro and Nakamura, Yuhei and Kawamura, Masakatsu and Takeshita, Junko and Yoshino, Nozomu and Gomyo, Ayumi and Kusuda, Machiko and Kimura, Shun-Ichi and Kako, Shinichi and Kanda, Yoshinobu},
title = {Serum thioredoxin at allogeneic haematopoietic stem cell transplantation predicts acute graft‐versus‐host disease},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70739}
}
EUVIMED